Provided by Tiger Fintech (Singapore) Pte. Ltd.

Soleno Therapeutics

79.38
+1.782.29%
Post-market: 79.380.00000.00%17:34 EDT
Volume:777.62K
Turnover:61.33M
Market Cap:4.00B
PE:-17.09
High:79.62
Open:77.96
Low:76.92
Close:77.60
Loading ...
Jun 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 29, 2024

Major Issues Report

Form 8-K - Current report
Apr 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 18, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities